Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gentell is the largest vertically-integrated wound care company globally, offering patient-specific wound management devices, advanced dressings, and skin protection products. Its proprietary honey-based wound dressing is reimbursable by Medicare and claims superior clinical results for chronic wounds, especially venous and pressure ulcers. Gentell has expanded rapidly through multiple acquisitions, global manufacturing, and deployment of a wound management technology platform. No clinical trial data for their devices is publicly available.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gentell.